The evolution of colistin resistance increases bacterial resistance to host antimicrobial peptides and virulence
eLife · 25.04.2023 · 12
DOI: 10.7554/elife.84395 ↗Kurz gefasst
Fachartikel in der Zeitschrift eLife, online erschienen am 25.04.2023. Verfasst von Pramod K Jangir und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology, University of Oxford, Oxford, United Kingdom. Hauptthemen laut MEDLINE: Bacterial Infections, Escherichia coli Proteins. Die Arbeit wurde bisher 50-mal zitiert (Crossref) und nennt 78 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust, Biotechnology and Biological Sciences Research Council, Medical Research Council.
Abstract (Originalsprache)
Antimicrobial peptides (AMPs) offer a promising solution to the antibiotic resistance crisis. However, an unresolved serious concern is that the evolution of resistance to therapeutic AMPs may generate cross-resistance to host AMPs, compromising a cornerstone of the innate immune response. We systematically tested this hypothesis using globally disseminated mobile colistin resistance (MCR) that has been selected by the use of colistin in agriculture and medicine. Here, we show that MCR provides a selective advantage to Escherichia coli in the presence of key AMPs from humans and agricultural animals by increasing AMP resistance. Moreover, MCR promotes bacterial growth in human serum and increases virulence in a Galleria mellonella infection model. Our study shows how the anthropogenic use of AMPs can drive the accidental evolution of resistance to the innate immune system of humans and animals. These findings have major implications for the design and use of therapeutic AMPs and suggest that MCR may be difficult to eradicate, even if colistin use is withdrawn.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biology, University of Oxford, Oxford, United Kingdom.
- Synthetic and Systems Biology Unit, Biological Research Centre, Eötvös Loránd Research Network, Szeged, Hungary.
- Doctoral School of Multidisciplinary Medical Sciences, University of Szeged, Szeged, Hungary.
- Guangdong Provincial Key Laboratory of Veterinary Pharmaceutics Development and Safety Evaluation, South China Agricultural University, Guangzhou, China.
- Fujian Provincial Key Laboratory of Soil Environmental Health and RegulaWon, College of Resources and Environment, Fujian Agriculture and Forestry University, Fuzhou, China.
- Beijing Advanced Innovation Centre for Food Nutrition and Human Health, College of Veterinary Medicine, China Agricultural University, Beijing, China.
ORCID-Profile: Pramod K Jangir, Csaba Pál
Förderung
- Wellcome Trust
- Biotechnology and Biological Sciences Research Council
- Medical Research Council
- National Natural Science Foundation of China
- European Research Council
- Hungarian Academy of Sciences
- National Research, Development and Innovation Office
- National Laboratories Program, National Laboratory of Biotechnology Grant
Zitieren
APA
Jangir, P. K., Ogunlana, L., Szili, P., Czikkely, M., Shaw, L. P., Stevens, E. J., Yu, Y., Yang, Q., Wang, Y., Pál, C., Walsh, T. R., & MacLean, C. R. (2023). The evolution of colistin resistance increases bacterial resistance to host antimicrobial peptides and virulence. eLife, 12. https://doi.org/10.7554/elife.84395
Vancouver
Jangir PK, Ogunlana L, Szili P, Czikkely M, Shaw LP, Stevens EJ, et al. The evolution of colistin resistance increases bacterial resistance to host antimicrobial peptides and virulence. eLife. 2023;12. doi:10.7554/elife.84395
BibTeX
@article{Jangir2023,
author = {Jangir, Pramod K and Ogunlana, Lois and Szili, Petra and Czikkely, Marton and Shaw, Liam P and Stevens, Emily J and Yu, Yang and Yang, Qiue and Wang, Yang and Pál, Csaba and Walsh, Timothy R and MacLean, Craig R},
title = {The evolution of colistin resistance increases bacterial resistance to host antimicrobial peptides and virulence},
journal = {eLife},
year = {2023},
volume = {12},
doi = {10.7554/elife.84395}
}
EUVIMED